|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.890 CNY | -0.40% |
|
-5.45% | -18.60% |
| 22/05 | Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug | MT |
| 19/05 | China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug | MT |
| Market Cap | 4.07B 601M 521M 480M 450M 841M 57.5B 859M 5.73B 2.22B 27.72B 2.25B 2.21B 96.37B | P/E Ratio 2023 |
61.7x | P/E Ratio 2024 | 79.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4.36B 644M 559M 515M 483M 902M 61.65B 921M 6.14B 2.38B 29.72B 2.42B 2.37B 103B | EV / Sales 2023 |
3.48x | EV / Sales 2024 | 2.95x |
| Free-Float |
40.31% | Yield 2023 |
1.62% | Yield 2024 | 1.57% |
| 1 day | -0.40% | ||
| 1 week | -5.45% | ||
| Current month | -8.17% | ||
| 1 month | -25.30% | ||
| 3 months | -38.38% | ||
| 6 months | -25.25% | ||
| Current year | -18.60% |
| 1 week | 9.65 |  | 10.49 |
| 1 month | 9.65 | | 13.04 |
| Current year | 9.65 | | 18.96 |
| 1 year | 9.65 | | 18.96 |
| 3 years | 6.81 | | 19.56 |
| 5 years | 6.81 | | 22.25 |
| 10 years | 6.81 | | 22.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Liu
CEO | Chief Executive Officer | 50 | 21/10/2018 |
Shen Hua Shi
DFI | Director of Finance/CFO | 63 | 16/04/2011 |
Chun Yan You
PRN | Corporate Officer/Principal | 50 | 18/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Xin Min Chen
CHM | Chairman | 60 | 21/10/2018 |
Zhi Jun Hua
CHM | Chairman | 57 | 16/04/2011 |
Jie Liu
BRD | Director/Board Member | 50 | 30/03/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.40% | -5.45% | -24.04% | -27.76% | 491M | |
| +2.74% | +3.51% | +44.04% | +161.56% | 1,013B | |
| +0.72% | +5.05% | +54.38% | +49.90% | 574B | |
| +1.10% | +0.91% | +18.53% | +64.81% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +14.78% | 280B | |
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | |
| +5.83% | +3.23% | +22.26% | +64.14% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +4.14% | -1.89% | +15.96% | +62.78% | 151B | |
| Average | +1.61% | +2.09% | +15.69% | +39.16% | 338.91B | |
| Weighted average by Cap. | +1.72% | +3.99% | +29.95% | +73.30% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 1.29B 191M 165M 153M 143M 267M 18.26B 273M 1.82B 704M 8.8B 716M 700M 30.6B | 1.18B 175M 151M 140M 131M 244M 16.71B 249M 1.67B 645M 8.05B 655M 641M 28B |
| Net income | 66.9M 9.87M 8.57M 7.9M 7.4M 13.83M 945M 14.11M 94.21M 36.48M 456M 37.06M 36.27M 1.58B | 39.88M 5.89M 5.11M 4.71M 4.41M 8.24M 564M 8.41M 56.17M 21.75M 272M 22.1M 21.62M 945M |
| Net Debt | 359M 52.97M 45.97M 42.37M 39.7M 74.18M 5.07B 75.73M 505M 196M 2.44B 199M 195M 8.5B | 294M 43.38M 37.65M 34.7M 32.52M 60.76M 4.15B 62.02M 414M 160M 2B 163M 159M 6.96B |
Employees
1,985
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/06/26 | 9.890 ¥ | -0.40% | 4,608,838 |
| 10/06/26 | 9.930 ¥ | -0.10% | 5,564,700 |
| 09/06/26 | 9.940 ¥ | +0.30% | 5,664,478 |
| 08/06/26 | 9.910 ¥ | -2.75% | 6,518,020 |
| 05/06/26 | 10.19 ¥ | +0.20% | 7,095,880 |
- Stock Market
- Stocks
- 002923 Stock
Select your edition
All financial news and data tailored to specific country editions
